Medical Devices · Healthcare
Head of Investor Relations, CFO
Head of Investor Relations
iRhythm Holdings, Inc. (IRTC)Equibles does not estimate personal net worth.
Get an email with a short summary when iRhythm Holdings, Inc. publishes a filing, an earnings call transcript or a press release.
Get IRTC alertsDaniel Wilson is recorded as Head of Investor Relations and CFO at iRhythm Holdings, Inc. (IRTC). The newest filing on record that lists Daniel Wilson as CFO at iRhythm Holdings, Inc. (IRTC) is dated April 17, 2026. The newest filing on record that lists Daniel Wilson as Head of Investor Relations at iRhythm Holdings, Inc. (IRTC) is dated April 11, 2024. iRhythm Holdings, Inc. reported in an 8-K filed August 1, 2024 that Daniel Wilson was appointed Chief Financial Officer, effective August 31, 2024. Daniel Wilson has spoken on 3 earnings calls across 1 company, most recently for iRhythm Holdings, Inc. on October 30, 2024. iRhythm Holdings, Inc. is classified in the Medical Devices industry within the Healthcare sector. Other leadership on record at iRhythm Holdings, Inc. includes Doug J. Devine (CEO), Douglas Devine (CEO), Quentin Blackford (CEO and Board Member) and 7 others.
“On July 31, 2024, the Board of Directors (the “Board”) of the Company appointed Daniel Wilson as the Company’s Chief Financial Officer and principal financial officer, effective as of August 31, 2024.”
“As a reminder, unless otherwise noted, the financial metrics that I discuss today will be presented on a non-GAAP basis. Reconciliations to GAAP can be found in today's earnings release and on our IR website.”
“I would like to start by expressing my excitement for the opportunity to step into the CFO role. I would like to thank Quentin, Brice, and the rest of the iRhythm team for positioning me for success and ensuring a smooth transition.”
Source not stated
Start not stated–present
Last confirmed April 11, 2024
Start not stated–present
Last confirmed April 17, 2026
Medical Devices · Healthcare
Head of Investor Relations, CFO